MLchartDataset catalogue

Yondelis

Term · Oncology and biomedicine · MLC-T-ONC-009441

A drug used to treat liposarcoma and leiomyosarcoma (types of soft tissue sarcoma) that cannot be removed by surgery or have spread to other parts of the body. It is used in patients who have already been treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Yondelis may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called ecteinascidin, ET 743, and trabectedin.

Table 1. Record
IdentifierMLC-T-ONC-009441
FieldOncology and biomedicine
Synonymsecteinascidin; ET 743; trabectedin
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009441",
  "term": "Yondelis",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat liposarcoma and leiomyosarcoma (types of soft tissue sarcoma) that cannot be removed by surgery or have spread to other parts of the body. It is used in patients who have already been treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Yondelis may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called ecteinascidin, ET 743, and trabectedin.",
  "synonyms": [
    "ecteinascidin",
    "ET 743",
    "trabectedin"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/yondelis/"
}

Record 17,545 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.